Just like GOLPH3, MYO18A is a driver of human cancers [16,28,31], and several have papers indicated that defective Golgi-to-PM trafficking might contribute to GOLPH3-driven malignant secretory phenotypes [29,32,33]. Here, MYO18A is linked to cancer.